KALC 2026

Invited Speakers

Triparna Sen

Ohio Univ.USA

Allison Chang

Harvard Medical SchoolUSA

Anne Gonzalez

Mcgill Univ.Canada

Anne-Marie Dingemans

Erasmus MC Cancer Institute, RotterdamNetherlands

Bernard Park

Memorial Sloan Kettering Cancer CneterUSA

Beung Chul Ahn

National Cancer CenterKorea

Cathleen June Park

UCI HealthUSA

Chi-Fu Jeffrey Yang

Massachusetts General HospitalUSA

Daniel Sterman

NYU Grossman School of MedicineUSA

David P. Carbone

Ohio State Univ.USA

David R. Gandara

University of CaliforniaUSA

Dohun Kim

Chungbuk National Univ.Korea

Edwin Ostrin

UT MD Anderson Cancer CenterUSA

Feng-Ming Kong

Univ. of Hong KongHong Kong

Florence Katie Keane

Mass General Brigham Cancer InstituteUSA

Florian J. Fintelmann

Massachusetts General HospitalUSA

Fred R. Hirsch

Mount SinaiUSA

Gary Lee

Univ. of Western AustraliaAustralia

Hee Sang Hwang

Univ. of UlsanKorea

Helena Yu

Memorial Sloan Kettering Cancer CenterUSA

Hideo Ichimura

Univ. of TsukubaJapan

Hisao Asamura

Keio Univ.Japan

Hongseok Yoo

Sungkyunkwan Univ.Korea

Hyo Yeong Ahn

Pusan National Univ.Korea

Hyun Ae Jung

Sungkyunkwan Univ.Korea

Hyungjin Kim

Seoul National Univ.Korea

Isabelle Opitz

Univ Hospital ZurichSwitzerland

Jay Moon Lee

UCLA HealthUSA

Jeong Uk Lim

The Catholic Univ. of KoreaKorea

Jeonghyo Lee

Seoul National Univ.Korea

Jessica Scott Donington

Univ. of ChicagoUSA

Jin-Hyoung Kang

The Catholic Univ. of KoreaKorea

Joachim Aerts

Erasmus MCNetherlands

Joe Y. Chang

MD AndersonUSA

Jonathan Spicer

McGill Univ.Canada

June hong Ahn

Yeungnam Univ.Korea

Junghee Lee

Sungkyunkwan Univ.Korea

Kenneth O'Byrne

Princess Alexandra HospitalAustralia

Keunchil Park

Sungkyunkwan Univ.Korea

Klaus Pantel

Univ. Medical Center Hamburg-EppendorfGermany

Kum Ju Chae

Jeonbuk National Univ.Korea

Kurt A. Schalper

Yale School of MedicineUSA

Kwon Joong Na

Seoul National Univ.Korea

Kwun Fong

Univ. of QueenslandAustralia

Kyu-Tae Han

National Cancer CenterKorea

Margarita Majem

Hospital de la Santa Creu I Sant PauSpain

Mari Mino-Kenudson

Massachusetts General HospitalUSA

Mattias Johansson

International Agency for Research on Lung Cancer, WHOSweden

Melinda C. Aldrich

Vanderbilt Univ.USA

Nicole Kiss

Deakin Univ.Australia

Pallav Shah

Royal Brompton HospitalUK

Pasi A. Jänne

Dana Famar InstituteUSA

Ricardo Sales dos Santos

ProPulmão InstituteBrazil

Ritu R. Gill

Columbia Univ.USA

Sally Ayesa

Univ. of SydneyAustralia

Scott Gettinger

Yale School of MedicineUSA

Sehui Kim

Sungkyunkwan Univ.Korea

Shankar Siva

Peter MacCallum Cancer CentreAustralia

Sonja Klebe

SA PathologyAustralia

Sue Sun Yom

Univ. of California San FranciscoUSA

Sun Min Lim

Yonsei Univ.Korea

Suresh Senan

Amsterdam Univ.Netherlands

Susan Scott

Johns Hopkins Univ.USA

Teh-Ying Chou

Taipei Medical Univ.Taiwan

Thomas Jones

Univ. College LondonUK

Valerie Rusch

Memorial Sloan Kettering Cancer CenterUSA

Yasuhiro Tsutani

Hiroshima Univ.Japan

Yong-Hyub Kim

Chonnam National Univ.Korea

Young-Ho Ahn

Ewha Womans Univ.Korea

Abstract No.	Presentation Time	Abstract Title	Presenter Name	Affiliation	Country
A-0125	15:10-15:20	Spatial Characterization of Immunosuppressive Microenvironment in Patients with PD-L1 Discordant Response to Pembrolizumab in Advanced Non-small Cell Lung Cancer	Seong-Eun Kim	Asan Medical Center	Korea
A-0115	15:20-15:30	Delta-like Ligand 3 (DLL3)-based Enrichment Enables Sensitive and Specific Detection of Circulating Tumor Cells During Immunotherapy in Small-cell Lung Cancer	Hyung-Joo Oh	Chonnam National University Medical School and Hwasun Hospital	Korea
A-0088	15:30-15:40	Cereblon (CRBN) Suppresses Lung Adenocarcinoma Cell Migration and Invasion by Facilitating the Degradation of Cystathionine Beta-Synthase (CBS)	Hyeon-Seung Yoon	Gwangju Institute Of Science And Technology	Korea
A-0022	15:40-15:50	In Vivo CRISPR Activation Screens Reveal Drivers of Chemoresistance in Small Cell Lung Cancer	Jae Heun Chung	Pusan National University Yangsan Hospital	Korea

Abstract No.	Presentation Time	Abstract Title	Presenter Name	Affiliation	Country
A-0103	09:10-09:20	Impact of Quitting Smoking at Diagnosis on Overall Survival in Lung Cancer Patients: A Comprehensive Meta-Analysis	Dongwon Park	Hanyang University Medical Center	Korea
A-0151	09:20-09:30	Transbronchial Mediastinal Cryobiopsy for Mediastinal Lesions: The First Single-Center Experience in South Korea	Min Jee Kim	Asan Medical Center	Korea
A-0021	09:30-09:40	Combining Deep Learning Radiomics with Clinical Data for Preoperative Prediction of STAS in Stage IA Lung Adenocarcinoma: a Multicenter Study	Xiaocui Liu	Union Hospital, Tongji Medical College, Huazhong University Of Science And Technology	China
A-0222	09:40-09:50	Exosome-based BALF liquid biopsy(ExoBAL)-guided pre-operative lazertinib therapy in potentially resectable EGFR-mutant tumors	In Ae Kim	Konkuk University Medical Center	Korea
A-0099	09:50-10:00	Localized Defense Programs Underlie Prognostic Divergence in GGO and Solid Lung Adenocarcinoma	Han Sanghyun	Chungbuk National University Hospital	Korea

Abstract No.	Presentation Time	Abstract Title	Presenter Name	Affiliation	Country
A-0072	10:25-10:35	Effectiveness and Radiation Pneumonitis of Stereotactic Body Radiation Therapy in High-Risk Patients with Early-Stage Non-Small Cell Lung Cancer	Yoo Kyung Choi	The Catholic University of Korea Seoul St. Mary's Hospital	Korea
A-0048	10:35-10:45	Identification of a novel Golgi Apparatus signature to prognostic stratification and integrative analyses in lung adenocarcinoma	Haoran Li	Sichuan Cancer Hospital	China
A-0077	10:45-10:55	Deep Learning-Driven Reconstruction of Lineage and Immune Plasticity Trajectories in Small Cell Lung Cancer Using Multi-Omics Data Integration	Rifaldy Fajar	The Integrated Mathematical, Computational, And Data Science For Biomedicine Research Foundation	Indonesia
A-0054	10:55-11:05	Tislelizumab vs Pembrolizumab for First-Line Treatment of Non-Small Cell Lung Cancer: Literature Review of Indirect Treatment Comparisons	Ji-Youn Han	National Cancer Center	Korea
A-0025	11:05-11:15	Predictive Value of Inflammatory Biomarkers in EGFR-Mutant NSCLC Treated with Lazertinib: An Interim Analysis of a Prospective Real-World Study (ORIENT)	Seung Hyeun Lee	Kyung Hee University Medical Center	Korea
A-0148	11:15-11:25	Integrated Gene Expression and Network Analysis Identifies Key Pathways in Small Cell Lung Cancer	Nadyatul Husna	Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang	Indonesia

Abstract No.	Poster No.	Abstract Title	Presenter Name	Affiliation	Country
A-0215	PE1-01	Clinical Relevance of Pleural Tissue Debris Incidentally Obtained During Catheter Drainage for Pleural Effusion	Jiwon Kim	Kyung Hee University Medical Center	Korea
A-0189	PE1-02	A Radiomics-based Nomogram for Preoperative Prediction of Pathological Subtypes in Nodular Lung Adenocarcinoma: a Multicenter Study	Xiaocui Liu	Union Hospital, Tongji Medical College, Huazhong University Of Science And Technology	China
A-0161	PE1-03	Dual Modulation of Redox and Immune Signaling in Lung Cancer via Pharmacoinformatic Study of Benzothiazepine-Based Immunomodulators Targeting Nrf2 and JAK2-JH1	Rizki Rachmad Saputra	Universitas Palangka Raya	Indonesia
A-0131	PE1-04	Molecular Adaptation Reveals Metabolic and Stress Response Bypass Pathways in Erlotinib-Resistant Non-Small Cell Lung Cancer Subclones	Nadyatul Husna	Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang	Indonesia
A-0118	PE1-05	Uncovering Multi-Layered Resistance Mechanisms to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer	Nadyatul Husna	Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang	Indonesia
A-0093	PE1-06	Natural Triterpenoids of Peronema canescens as Dual Inhibitors of AKT1 and ERK1/2: A Structure-Based Approach for Overcoming Lung Cancer	Rizki Rachmad Saputra	Universitas Palangka Raya	Indonesia
A-0076	PE1-07	Development of a Novel Inhibitor Against nRAS-Mutated Lung Cancers.	Vikas Kumar	Aiims New Delhi	India
A-0059	PE1-08	Solid Lipid Nanoparticle of Ganodric acid ameliorate benzopyrene induced lung cancer in rats Via Alteration of Nrf2/HO-1 Signaling pathway	V Kumar	Shalom Institute Of Health & Allied Sciences	India
A-0236	PE1-09	Decoding the Role of myomiR-206 in Lung Cancer Cachexia and Its Correlation with IL-6 Signaling	Divo Helmizar	Stan / Perbendaharaan Negara	Indonesia
A-0233	PE1-10	Decoding Hematologic Paraneoplastic Syndromes in Lung Cancer: A Critical Approach to Early Diagnosis	Aryofri Afan	Andalas University	Indonesia
A-0220	PE1-11	Establishment of a Lung Organoid Library from Diverse Clinical Samples for Advanced Disease Modeling	Joo-Eun Lee	Chungnam National University Hospital	Korea
A-0208	PE1-12	Role of PFKFB3 in Maintaining Redox Homeostasis and DNA Integrity in Non-Small Cell Lung Cancer Cells Treated with EGFR-TKIs	Brijalkumar Patel	Gmers Medical College	India
A-0207	PE1-13	Follicular lymphoma presenting with solitary pulmonary nodule: two case reports	Heae Surng Park	Ewha Womans University Medical Center	Korea
A-0181	PE1-14	Nutritional and Lifestyle Interventions in Lung Cancer Prevention and Survivorship in Indonesia	Helen Try Juniasti	Cendrawasih University	Indonesia
A-0174	PE1-15	Enhancing Quality of Life in Lung Cancer Patients: Integrating Palliative Care with Immunotherapy and Targeted Therapy	Yesika Simbolon	Atmajaya University	Australia
A-0134	PE1-16	Genetic Analysis of Compositions For Diagnosing Lung Cancer Comprising Peptide Nucleic Acid Probe Complementary To Lung Cancer Related Mutations	Ramlah Ramlah	Universitas Sulawesi Barat esia	Indonesia
A-0100	PE1-17	Spread Through Air Spaces in EGFR-mutated Lung Adenocarcinomas: Prevalence and Prognostic Significance	Yeon Bi Han	Seoul National University Bundang Hospital	Korea
A-0095	PE1-18	Decoding Alternative Splicing-Driven Immune Escape in Rare Lung Adenocarcinoma Subtypes Using Deep Learning and Minor Spliceosome Signatures	Rini Winarti	Yogyakarta State University	Indonesia
A-0081	PE1-19	Integrated Multi-Omics Profiling Identifies CEBPA as an Aging-Related Prognostic Biomarker in NSCLC	Jiaqi Zhu	Affiliated Hospital Of Nantong University	China
A-0038	PE1-20	Investigating the Role and Mechanisms of USP18-Mediated YAP Deubiquitination in Radiation-Induced Lung Injury	Haochun Guo	Zhongda Hospital, Medical School Of Southeast University	China
A-0037	PE1-21	Exploring the protection effects of Taxifolin on alleviating radiation-induced lung injury basing on USP18	Haochun Guo	Zhongda Hospital, Medical School Of Southeast University	China
A-0035	PE1-22	Comprehensive Analysis of Matrisome-Related Genes Reveals Prognostic Value and Immune Landscape in Lung Cancer	Hou Wang	Ningbo No.2 Hospital	China

Abstract No.	Poster No.	Abstract Title	Presenter Name	Affiliation	Country
A-0096	PE1-23	A Peritumor-based Model Combining 3D Deep Learning and Radiomics for Preoperatively Predicting STAS in Invasive Lung Adenocarcinoma: a Multicenter Study	Xiaocui Liu	Union Hospital, Tongji Medical College, Huazhong University Of Science And Technology	China
A-0244	PE1-24	Machine Learning Algorithms' Use in Plasma Biomarker-Based Lung Cancer Diagnosis	Siska Azizah	Baiturrahmah Universitya	Indonesia
A-0211	PE1-25	An AI-powered holotomography platform for predicting drug response in patient-derived lung cancer organoids	Mahn Jae Lee	Chungnam National University Hospital	Korea
A-0135	PE1-26	Development of Big Data for Predecting Lung Cancar (Study in Asia)	Rara Yulianda	Sulthan Thaha Saifuddin Islamic State University	Indonesia
A-0132	PE1-27	Enhancing using Artificial Intelligence in Detecting Lung Cancer in Asia	Rani Marsyanda	Sultan Thaha Saifuddin Islamic State University	Indonesia
A-0120	PE1-28	A Comprehensive Review of Legal and Ethical in the Implementation of AI & Big Data in Lung Cancer Diagnosis	Ferza Alfath	Alumnus Universitas Andalas	Indonesia
A-0119	PE1-29	AI-Driven Multi-Modal Prediction of Post-Surgical Recurrence in Brain-Metastatic Lung Adenocarcinoma: Integrating Tumor Dormancy, Stromal Remodeling, and TME Immune Exclusion Signals	Elfiany Syafruddin	Blk Muhammadiyah University	Indonesia
A-0075	PE1-30	Comparative Risk of Neurological Adverse Events Between PD-1 and PD-L1 Inhibitors in Korean Lung Cancer Patients: A Nationwide Cohort Study	Seung Hyeun Lee	Kyung Hee University Medical Center	Korea
A-0067	PE1-31	Applying machine learning (ML) and artificial intelligence (AI) techniques to predict the risk of lung cancer in region of Chhattisgarh.	Manvendra Singh	Hmfa Miet	India

Others
Abstract No.	Poster No.	Abstract Title	Presenter Name	Affiliation	Country
A-0170	PE1-32	Assessment of the association between expression of Cyclin D1 protein with the clinicopathological characteristics and prognosis of lung cancer	Usha J Satanee	Nanduba Medical Center	India
A-0127	PE1-33	Trends of positive rates of initial screening and repeated screening in national organized population-based lung cancer screening in Korea	Nayoung Lee	National Cancer Center	Korea
A-0217	PE1-34	Economic Burden and Cost-Effectiveness of Lung Cancer Management in Indonesia: Evidence from Smoking-Attributable Mortality and EGFR-Targeted Therapies	Pisi Bethania Titalessy	Universitas Cenderawasih	Indonesia
A-0117	PE1-35	Highly Sensitive Digital Profiling of Tumor-derived Extracellular Vesicle RNA for EML4-ALK Mutations in Non-small Cell Lung Cancer	Beomseok Lee	Labspinner, Inc.	Korea
A-0173	PE1-36	Impact Evaluation of Cigarette Excise and Pricing on Smoking Habits and Lung Cancer Disease in Indonesia	Lintong Hottua Simbolon	The Pranala Institute	Indonesia

Radiology / Staging / Screening / Epidemiology
Abstract No.	Poster No.	Abstract Title	Presenter Name	Affiliation	Country
A-0232	PE1-40	Long-Term Projections of Tracheal, Bronchus, and Lung Cancer in Indonesia’s Productive-Age Population	Najwa Aisya Putri	International Open University	Indonesia
A-0225	PE1-41	Contrasting Mortality Patterns of Lung Cancer in Young Adults (25-29 Years) Across Global Socio-Demographic Contexts, 2015-2021	Najwa Aisya Putri	International Open University	Indonesia
A-0223	PE1-42	Divergent Global Trends in Lung Cancer Mortality Among Young Adults (25-29 Years) by Socio-Demographic Index: Projections to 2050	Najwa Aisya Putri	International Open University	Indonesia
A-0205	PE1-43	Mapping the Burden of Tracheal, Bronchus, and Lung Cancer: Age-Based and SDI-Level Comparisons from the GBD 2021	Nabila Zahra Athirah	Islamic University Of Indonesia	Indonesia
A-0204	PE1-44	Unveiling the Burden of Smoking on Lung Cancer in Indonesia: A Quantitative Assessment from 2017 to 2021	Najwa Aisya Putri	International Open University	Indonesia
A-0031	PE1-45	Indoor air pollution and risk of hypopharyngeal/laryngeal and lung cancers in New Delhi, India	Monirujjaman Biswas	Jawaharlal Nehru University	India
A-0030	PE1-46	Examining the differences between non-smokers and smokers of lung cancer: Insights from a Tertiary Centre in Delhi, India	Monirujjaman Biswas	Jawaharlal Nehru University	India
A-0020	PE1-47	Trends and Survival Outcomes of Lung Cancer Surgery in South Korea, 2015-2019	Chanwoo Kim	Chungbuk National University	Korea
A-0243	PE1-48	Regional Trends in Lung Cancer in Southeast Asia: Analysis of Mortality Proportion, Daily Life Expectancy (DALYs), and Prevalence	Derizal Derizal	Ip Trisakti	Indonesia
A-0239	PE1-49	Identification of Environmental, Behavioral, and Metabolic Risk Factors for Lung Cancer Mortality: A Statistical Approach	Putri Ayu	Andalas University	Indonesia
A-0201	PE1-50	Preventing Chronic Lung Disease Early: Evidence of the Impact of Parenting and Mental Health from the Indonesian Family Life Survey	Derizal Derizal	Ip Trisakti	Indonesia
A-0087	PE1-51	User Satisfaction and Reading Efficiency of an AI-Based Quality Control System in Korean National Lung Cancer Screening	Kang Jegu	National Cancer Center	Korea
A-0086	PE1-52	Urban-Rural Disparities in Lung Cancer Diagnosis and Treatment in Indonesia: A Nationwide Review	Rinita Istiqomah	Universitas Jambi	Indonesia
A-0074	PE1-53	Single Round LDCT Screening in Men Aged 70 Years: Prevalence of Pulmonary Nodules and Lung Cancer Detection	Hyerin Kang	Dongtan Sacred Heart Hospital	Korea
A-0056	PE1-54	Air Pollution and Lung Cancer in a Changing Climate Through Projected Risks and Molecular Impacts of PM2.5 Exposure	Firdian Makrufardi	Integrated Medical, Molecular, And Data Science Research Foundation	Indonesia
A-0027	PE1-55	Sex-Specific Associations of Total Bilirubin, ALBI, and PALBI with Lung Cancer Risk: Interactions with Smoking and Alcohol	Jong Won Shin	Asan Medical Center	Korea
A-0026	PE1-56	Risk and Incidence of Drug-Induced Interstitial Lung Disease Associated with Anti-Neoplastic Therapy: A Nationwide Population-Based Study in Korea	Seung Hyeun Lee	College of Medicine, Kyung Hee University, Kyung Hee University Hospital	Korea
A-0019	PE1-57	Association between Creatinine and Lung Cancer Risk in Men Smokers: A Comparative Analysis with Antioxidant Biomarkers from the KCPS-II Cohort	Jong Won Shin	Asan Medical Center	Korea

Mesothelioma / Thymic & Other Thoracic Malignancies
Abstract No.	Poster No.	Abstract Title	Presenter Name	Affiliation	Country
A-0203	PE2-08	Uncovering the Growing Burden of Mesothelioma: A Five-Year Analysis in Southeast Asia Using CAGR	Nabila Zahra Athirah	Islamic University Of Indonesia	Indonesia
A-0202	PE2-09	Prognostic Impact of Histologic Subtype, Age, and Systemic Immune-Inflammation Index in Surgically Treated Malignant Pleural Mesothelioma	Song Ee Park	The Catholic University of Korea Seoul St. Mary's Hospital	Korea
A-0200	PE2-10	Exploring Mesothelioma Outcomes Among Working-Age Women: A Five-Year Global Study of Prevalence and Mortality Trends	Najwa Aisya Putri	International Open University	Indonesia
A-0177	PE2-11	Correlation of CT and PET Imaging Responses with Pathological Outcomes after Neoadjuvant Treatment for Thymic Tumors	Hyeon Seok Choi	Seoul National University Hospital	Korea
A-0102	PE2-12	Rare Mutation, Real Impact: Durable Response In EGFR-Mutated Sarcomatoid Lung Cancer	Noor Nabila Binti Mohamad	National Cancer Institute	Malaysia
A-0090	PE2-13	Mathematical Modeling of Treg-TAM Crosstalk and TNFR2 Immunotherapy Timing in Thymic and Mesothelial Tumors Post-Chemotherapy	Prihantini Prihantini	The Integrated Mathematical, Computational, And Data Science For Biomedicine Research Foundation	Indonesia
A-0024	PE2-14	Malignant Pleural Mesothelioma at Pham Ngoc Thach Hospital in 10-Year Retrospective Study	Nguyen Son Lam	Pham Ngoc Thach Hospital (retired)	Vietnam

Surgery
Abstract No.	Poster No.	Abstract Title	Presenter Name	Affiliation	Country
A-0079	PE2-18	A Comparative Analysis of Sublobar versus Lobar Resection for Early-Stage Non-Small Cell Lung Cancer in Octogenarian Patients	Sangil Yun	Seoul National University	Korea
A-0227	PE2-19	Racial and Ethnic Disparities in Surgical Management of Early-Stage Non-Small Cell Lung Cancer: A population-Based Analysis	Ahmed Almezaine	Ministry Of Health	Egypt
A-0182	PE2-20	Long-Term Outcomes After ICU Discharge Among Lung Cancer Patients: A Longitudinal Analysis of Physical, Cognitive, and Emotional Health Across Age	Silmi Rahmani	The Pranala Institute	Indonesia
A-0176	PE2-21	Caregiver Dynamics and Surgical Recovery in Lung Cancer: Perception, Knowledge, Attitude, and Patient Quality of Life in Indonesia	Hepri Ardianson Purba	The Pranala Institute	Indonesia

KALC 2026 SIGN-UP NOTICE

KALC 2026 INTERNATIONAL CONFERENCE

KALC 2026 INTERNATIONAL CONFERENCE